Protocol Design

Latest News

Credit: Gorodenkoff | stock.adobe.com
The Value of Clinical Trial Liaisons in the Drug Development Lifecycle

February 4th 2025

Clinical trial liaisons rather serve as experts in their therapeutic areas and as clinical trial specialists to provide a suite of strategic advantages to benefit a study.

Leveraging AI/Machine Learning as an End-to-End Differentiator
Leveraging AI/Machine Learning as an End-to-End Differentiator

December 12th 2024

Moving Towards Decentralized Elements: Q&A with Scott Palmese, Worldwide Clinical Trials
Moving Towards Decentralized Elements: Q&A with Scott Palmese, Worldwide Clinical Trials

December 6th 2024

© Egor - © Egor - stock.adobe.com
The Importance of Using Cognition as an Endpoint in Clinical Trials

December 3rd 2024

Sticking to the Plan: Undue Burden Created by Protocol Deviations
Sticking to the Plan: Undue Burden Created by Protocol Deviations

July 26th 2024

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.